Leading Experts Discuss Current and Future Applications of Next Generation Sequencing in Pathology

Report this content

College of American Pathologists hosts free webinar on Genomic Medicine: July 23, 2:00 p.m. CDT

WHAT:  Genomic medicine has the potential to be a cornerstone of medical testing, treatment, and clinical integration. What does it mean for patients, physicians, and the health care system overall?

The College of American Pathologists (CAP) will host a one-hour webinar where leading experts will discuss how pathologists are leveraging this technology in gene sequencing to aid in cancer diagnosis and treatment. The expert panel also will explore applications in hereditary diseases.

Genomic Analysis “Emergent Leadership Potential for Pathologists”
Tuesday, July 23
2:00-3:00 PM (CDT)

Registration is FREE.

This webinar complements chapter 8 of the CAP’s new ebook: New Paths...New Choices: Pathology in an Era of Advancing Science and Disruptive Health Economics. Download your free copy of the CAP ebook.

WHO:   The expert panel consists of early adopters and those entering the field.

Debra G.B. Leonard, MD, PhD, FCAP
Chair and Professor, Department of Pathology, University of Vermont College of Medicine, Burlington
Physician Leader, Department of Pathology & Laboratory Medicine, Fletcher Allen Health Care, UVM College of Medicine, Burlington
Chair, CAP Personalized Healthcare Committee

John D. Pfeifer, MD, PhD, FCAP
Vice Chair for Clinical Affairs, Department of Pathology, and Immunology, Washington University School of Medicine, St. Louis
Professor, Pathology and Immunology, and Professor, Obstetrics and Gynecology, also at Washington University

Gail H. Vance, MD, FCAP
Professor of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis
Professor of Pathology and Laboratory Medicine and Director of the Division of Diagnostic Genomics, also at Indiana University

Drs. Leonard, Pfeifer, and Vance are featured in the CAP’s ebook chapter on genomic analysis.Dr. Vance also leads the CAP genomic strategy initiative.

WHY: The emerging field of next generation sequencing holds promise for patients in aiding in cancer diagnosis, leading to more personalized treatment options. These individualized treatment plans have the potential for cost savings across the health care system.

About the CAP

As the leading organization for board-certified pathologists, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. With more than 18,000 physician members, the CAP has led as the gold standard in laboratory accreditation for 50 years with nearly 7,500 CAP-accredited laboratories in 50 countries. Find more information about the CAP at cap.org.

About the College of American Pathologists

As the leading organization for board-certified pathologists, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. With more than 18,000 physician members, the CAP has led as the gold standard in laboratory accreditation for 50 years with more than 7,300 CAP-accredited laboratories in 50 countries. Find more information about the CAP at cap.org.

About the CAP

As the leading organization for board-certified pathologists, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. With more than 18,000 physician members, the CAP has led as the gold standard in laboratory accreditation for 50 years with nearly 7,500 CAP-accredited laboratories in 50 countries. Find more information about the CAP at cap.org.

Tags:

Documents & Links